Intraperitoneal tuberculosis abscess in pregnancy presenting as an adnexal mass: a case report
Intraperitoneal tuberculosis abscess in pregnancy presenting as an adnexal mass: a case report
复制标题
DOI:
10.1080/01443615.2019.1679739
复制
发表时间:
2019-12-10
影响因子:
1.3
通讯作者:
Ocal, Pelin
中科院分区:
文献类型:
--
作者:
Erenel, Hakan;Alpay, Verda;Ocal, Pelin
DiscussionIntraperitoneal tuberculosis is a form of abdominal tuberculosis that emerges from the lymphatic system, omentum, intestinal tract, liver, spleen or female genital tract and peritoneum (Malik and Saxena Citation 2003). Intraperitoneal tuberculosis which accounts only 1–2% of the cases of tuberculosis may present with low grade fever, abdominal pain, weight loss, abdominal distension, elevated CA-125 levels, ascites and/or adnexal mass (Wu et al. Citation 2011). In pregnancy, intraperitoneal tuberculosis is extremely rare and the diagnosis is usually delayed because of vague symptoms of the disease and the clinical effects of the pregnancy itself (Lee et al. Citation 2005). Intraperitoneal tuberculosis in pregnancy presented as an adnexal mass may be misdiagnosed as malignancy due to the similarity of the symptoms. Once an adnexal mass is encountered in a pregnant woman, especially in developing countries, intraperitoneal tuberculosis abscess should be suspected. Although laparoscopy or laparotomy and biopsy is the gold standard method in case of intraperitoneal tuberculosis, a computed tomography and ultrasound guided biopsy of suspicious lesions can be performed (Wu et al. Citation 2019). We preferred ultrasound guided biopsy since the ovaries were normal on MRI and the mass was interpreted as an abscess or a mass derived from lymph nodes. Following the diagnosis of the intraperitoneal tuberculosis in pregnancy, treatment should start immediately to prevent congenital tuberculosis and obstetric complications such as spontaneous abortion, preterm labour and low birth weight (Loto and Awowole Citation 2012). World Health Organisation recommends ethambutol, isoniazid, rifampicin and pyrazinamide for 2 months–the intensive phase–followed by 4 months of isoniazid and rifampicin–the continuation phase (World Health Organization and Stop TB Initiative Citation 2010). Centers for Disease Control and Prevention guidelines do not endorse pyrazinamide in pregnancy because its effect on the fetus is unknown (Centers for Disease Control Citation 2003). In our case, leukocyte count was 13× 10 3/mm 3 which is accepted within normal limits for pregnant population (Lurie et al. Citation 2008). CA-125 levels might also be accepted within normal limits in our case because CA 125 levels are also increased in pregnancy (Bon et al. Citation 2001). In the presence of an adnexal mass, unclear symptoms and laboratory findings like in our case, physician may be confused this with ovarian cancer. Visualisation of normal ovaries is crucial. This clinical approach may lead to hasty, unnecessary and extensive surgery, whereas tuberculosis is a highly curable disease with antituberculous treatment.